KDM1A and diffuse large B-cell lymphoma: Although LSD1 knockdown inhibits the proliferation of DLBCL cell lines in vitro, pharmacologic inhibition of the enzymatic activity of LSD1 only shows modest effects against DLBCL in vivo (Hatzi et al., 2019).